EN IT

Reserved

Beam Therapeutics azioni recupera il 7,7%, ma il Segnale di Vendita non arretra

·47 min read
EXECUTIVE VIEW

Beam Therapeutics analisi tecnica settimanale: il Segnale di Vendita è alla quarta settimana, con un rimbalzo del 7,7% che non convince i flussi di denaro. Forza del segnale a 2, ranking 61ª su 122 vendite USA.

Reserved analysis Subscribe to read →
Reserved

Beam Therapeutics stock bounces 7.7%, but the Sell signal holds its ground

·46 min read
EXECUTIVE VIEW

Beam Therapeutics weekly technical analysis: the Sell signal enters its fourth week after a 7.7% bounce, with daily money flow still negative and swing trading price action turning cautious into the close.

Reserved analysis Subscribe to read →
Reserved

Beam Therapeutics azioni: rimbalzo dell'1,7% non ferma i massimi decrescenti

·46 min read
EXECUTIVE VIEW

Le azioni Beam Therapeutics restano nel Segnale di Vendita alla terza settimana: analisi tecnica settimanale su Forza, distribuzione e livelli chiave dopo un rimbalzo dell'1,7% con tre massimi decrescenti.

Reserved analysis Subscribe to read →
Reserved

Beam Therapeutics stock: 1.7% bounce fails to break the pattern of lower highs

·46 min read
EXECUTIVE VIEW

Beam Therapeutics stock stays in a Sell signal in its third week: weekly technical analysis of signal strength, distribution and key levels among healthcare stocks after a 1.7% bounce inside a pattern of lower highs.

Reserved analysis Subscribe to read →
Reserved

Beam Therapeutics cede l'8,8% e il segnale di vendita sale al 3° posto

·46 min read
EXECUTIVE VIEW

Analisi tecnica su azioni Beam Therapeutics: settimana di conferma del segnale di vendita chiusa in calo (-8,8%), venditori dominanti e distribuzione in corso. Il nostro modello segnala alto rischio.

Reserved analysis Subscribe to read →
Reserved

Beam Therapeutics drops 8.8% as the sell signal climbs to 3rd place

·46 min read
EXECUTIVE VIEW

Beam Therapeutics weekly technical analysis: the sell signal's confirmation week closes lower (-8.8%), with dominant sellers and a distribution phase underway. Our model flags high risk.

Reserved analysis Subscribe to read →
Reserved

Beam Therapeutics cede il 15,8%: il rimbalzo si spegne sotto la pressione dei venditori

·46 min read
EXECUTIVE VIEW

Azioni Beam Therapeutics, analisi tecnica settimanale: nuovo segnale di vendita, 2° su 140 titoli USA. Il titolo cede il 15,8% mentre il rimbalzo si spegne sotto la pressione estrema dei venditori, con volatilità molto elevata.

Reserved analysis Subscribe to read →
Reserved

Beam Therapeutics drops 15.8% as the rebound gets crushed by sellers

·46 min read
EXECUTIVE VIEW

Beam Therapeutics weekly technical analysis: a fresh sell signal ranks 2nd among 140 US stocks. The stock drops 15.8% as the rebound fails under extreme selling pressure, price action turning fully bearish with volatility very high.

Reserved analysis Subscribe to read →
Reserved

Beam Therapeutics cede il 6,1%: venditori al comando, denaro in negativo

·47 min read
EXECUTIVE VIEW

Beam Therapeutics analisi tecnica settimanale: il titolo cede il 6,1% con i venditori dominanti e il flusso di denaro girato in negativo, mentre l'ADX continua a salire e il trend di fondo prende convinzione nonostante il ritracciamento.

Reserved analysis Subscribe to read →
Reserved

Beam Therapeutics drops 6.1%: sellers in control, money flow turns negative

·47 min read
EXECUTIVE VIEW

Beam Therapeutics weekly technical analysis: the stock drops 6.1% as sellers dominate and money flow turns negative, while the ADX keeps climbing and the underlying trend gains conviction despite the pullback.

Reserved analysis Subscribe to read →
Reserved

Beam Therapeutics a +10,83% dall'ingresso, copertura del modello completata

·46 min read
EXECUTIVE VIEW

Beam Therapeutics è all'11ª settimana di un segnale di acquisto, in guadagno del 10,83% dall'ingresso. I 3 target del nostro modello più evoluto sono stati raggiunti e lo stop segue ora il Punto di Inversione, in area 29,6.

Reserved analysis Subscribe to read →
Reserved

Beam Therapeutics up 10.83% since entry, model coverage complete

·46 min read
EXECUTIVE VIEW

Beam Therapeutics technical analysis: week 11 of a buy setup, up 10.83% since entry. All 3 targets of our most advanced model have been hit, and the stop now trails the Inversion Point, in the 29.6 area.

Reserved analysis Subscribe to read →
Reserved

Beam Therapeutics alla 10ª settimana: tutti i riferimenti statistici toccati, ma la conferma è debole

·46 min read
EXECUTIVE VIEW

Beam Therapeutics alla 10ª settimana di acquisto, a +10.9% dall'ingresso. Tutti e 3 i riferimenti statistici sono stati toccati, ma la settimana di conferma è chiusa in calo: il modello segnala di valutare l'uscita. Un trade solido, ora in fase di decisione.

Reserved analysis Subscribe to read →
Reserved

Beam Therapeutics at week 10: all statistical targets hit, confirmation still weak

·46 min read
EXECUTIVE VIEW

Beam Therapeutics weekly trade setup at week 10, +10.9% performance since entry. All 3 statistical price targets reached, but the confirmation week closed bearish: the model flags a potential exit. A strong trade now at a decision point. Technical analysis via AiTrading67.

Reserved analysis Subscribe to read →
Share WhatsApp Telegram Gmail LinkedIn